The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.
Netea MG, Ferwerda G, de Jong DJ, Werts C, Boneca IG, Jéhanno M, Van Der Meer JW, Mengin-Lecreulx D, Sansonetti PJ, Philpott DJ, Dharancy S, Girardin SE.
J Biol Chem. 2005 Oct 28;280(43):35859-67. Epub 2005 Aug 22.PMID: 16115863 [PubMed - indexed for MEDLINE]Related articlesFree article